Omeros OMER
NASDAQ OMER
$18.95 -0.16 (-0.84%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omeros (OMER) Change in Acquisitions & Divestments (2010 - 2026)

Omeros (OMER) posted Change in Acquisitions & Divestments of $30.0 million for Q1 2026, down 21.74% sequentially from $38.4 million in Q4 2025, and down 23.54% YoY from $39.3 million in Q1 2025.

Analysis

Omeros (OMER) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

Omeros has reported Change in Acquisitions & Divestments for 17 years, with the latest figure at $30.0 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 23.54% year-over-year to $30.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100.6 million (down 85.27% YoY) and the FY2025 annual result came in at $109.9 million, down 89.73% from the prior year.
  • Change in Acquisitions & Divestments fell to $30.0 million in Q1 2026 per OMER's latest filing, from $38.4 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $425.7 million in Q1 2024 and troughed at $6.2 million in Q1 2022.
  • A 5-year average of $150.5 million and a median of $100.5 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments soared 5425.97% in 2023, then sank 96.84% in 2025.
  • Over 5 years, Change in Acquisitions & Divestments stood at $217.0 million in 2022, then jumped by 36.12% to $295.4 million in 2023, then tumbled by 65.96% to $100.5 million in 2024, then sank by 61.81% to $38.4 million in 2025, then dropped by 21.74% to $30.0 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $30.0 million, $38.4 million, and $10.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.60 Mn
Mar 31, 2026 30.05 Mn
Dec 31, 2025 38.40 Mn
Sep 30, 2025 10.50 Mn
Jun 30, 2025 21.70 Mn
Mar 31, 2025 39.30 Mn
Dec 31, 2024 100.55 Mn
Sep 30, 2024 331.81 Mn
Jun 30, 2024 211.73 Mn
Mar 31, 2024 425.69 Mn
Dec 31, 2023 295.37 Mn
Sep 30, 2023 234.06 Mn
Jun 30, 2023 174.45 Mn
Mar 31, 2023 342.61 Mn
Dec 31, 2022 216.99 Mn
Sep 30, 2022 33.40 Mn
Jun 30, 2022 45.00 Mn
Mar 31, 2022 6.20 Mn
Dec 31, 2021 18.50 Mn
Sep 30, 2021 18.00 Mn